Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Gemcitabine and Docetaxel in Advanced Sarcoma
NCT01879085Phase 2Completed
- Start
- Sep 2013
- Primary completion
- Apr 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in soft tissue sarcoma (STS). Started Sep 2013; status: completed.
02
Drugs
vorinostat
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01879085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01879085.